DAVOS WATCH: ‘The Fragile Future of Antibiotics’

Credit: World Economic Forum

‘Antimicrobial resistance (AMR) is already undermining modern medicine. As superbugs evolve faster than new treatments can be developed, once-manageable infections are becoming harder to cure, threatening everything from surgery to cancer care.

‘How can we ensure global access to life-saving antibiotics while preserving their effectiveness for generations to come?’

Speakers:

• Deepak Nath — Chief Executive Officer, Smith+Nephew
• Stanley M. Bergman — Chairman of the Board and Chief Executive Officer, Henry Schein
• Vanina Laurent-Ledru — Chief Public Health & Government Affairs Officer, Institut Mérieux
• Mosa Moshabela — Vice-Chancellor and Principal, University of Cape Town
• Rachel Glennerster — President, Center for Global Development